Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer

被引:2
|
作者
Zhang, Xiu-Xia [1 ,3 ]
Yu, Xin [1 ]
Zhu, Li [2 ]
Luo, Jun-Hua [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thyroid & Breast Surg, Linping Campus, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Pathol Dept, Linping Campus, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thyroid & Breast Surg, 369 Yingbin Rd,Nanyuan St,Linping Campus, Hangzhou 311100, Zhejiang, Peoples R China
关键词
biomarkers; breast cancer; prognosis; risk model; senescence; TUMOR-ASSOCIATED MACROPHAGES; IMMUNOSURVEILLANCE; INVASION;
D O I
10.1097/MD.0000000000035923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study focused on screening novel markers associated with cellular senescence for predicting the prognosis of breast cancer. The RNA-seq expression profile of BRCA and clinical data were obtained from TCGA. The pam algorithm was used to cluster patients based on senescence-related genes. The weighted gene co-expression network analysis was used to identify co-expressed genes, and LASSO-Cox analysis was performed to build a risk prognosis model. The performance of the model was also evaluated. We additionally explored the role of senescence in cancer development and possible regulatory mechanism. The patients were clustered into 2 subtypes. A total of 5259 genes significantly related to senescence were identified by weighted gene co-expression network analysis. LASSO-Cox finally established a 6-signature risk model (ADAMTS8, DCAF12L2, PCDHA10, PGK1, SLC16A2, and TMEM233) that exhibited favorable and stable performance in our training, validation, and whole BRCA datasets. Furthermore, the superiority of our model was also observed after comparing it to other published models. The 6-signature was proved to be an independent risk factor for prognosis. In addition, mechanism prediction implied the activation of glycometabolism processes such as glycolysis and TCA cycle under the condition of senescence. Glycometabolism pathways were further found to negatively correlate with the infiltration level of CD8 T-cells and natural killer cells but positively correlate with M2 macrophage infiltration and expressions of tissue degeneration biomarkers, which suggested the deficit immune surveillance and risk of tumor migration. The constructed 6-gene model based on cellular senescence could be an effective indicator for predicting the prognosis of BRCA.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Identification of a 6-gene signature predicting prognosis for colorectal cancer
    Zuo, Shuguang
    Dai, Gongpeng
    Ren, Xuequn
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [22] RETRACTED ARTICLE: Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer
    Tiancheng Li
    Siqi Chen
    Yuqi Zhang
    Qianqian Zhao
    Kai Ma
    Xiwei Jiang
    Rongwu Xiang
    Fei Zhai
    Guixia Ling
    Functional & Integrative Genomics, 2023, 23
  • [23] Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients
    A. W. Mao
    H. Barck
    J. Young
    A. Paley
    J. -H. Mao
    H. Chang
    Clinical and Translational Oncology, 2022, 24 : 597 - 604
  • [24] Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients
    Mao, A. W.
    Barck, H.
    Young, J.
    Paley, A.
    Mao, J-H
    Chang, H.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (03): : 597 - 604
  • [25] Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes
    Wang, Yue
    Dai, Longfei
    Huang, Ran
    Li, Weisong
    Wu, Wenyong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Identification and evaluation of a risk model predicting the prognosis of breast cancer based on characteristic signatures
    Ying, Yu
    Yang, Meifeng
    Chen, Jiaying
    Yao, Chang
    Bian, Weihe
    Wang, Cong
    Ye, Bei
    Shen, Tong
    Guo, Mengmeng
    Zhang, Xiping
    Cao, Sihan
    Ma, Chaoqun
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (06) : 1441 - +
  • [27] A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer
    Lei, Liangliang
    Li, Nannan
    Yuan, Pengfei
    Liu, Dechun
    BMC CANCER, 2022, 22 (01)
  • [28] A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer
    Liangliang Lei
    Nannan Li
    Pengfei Yuan
    Dechun Liu
    BMC Cancer, 22
  • [29] A serum LncRNA signature for predicting prognosis of triple-negative breast cancer
    Zhu, Ting
    Wang, Junjun
    Li, Juan
    Zhang, Qichao
    Shang, Yanyan
    Zhou, Junhao
    Min, Ling
    Lv, Bo
    Luo, Kai
    CLINICA CHIMICA ACTA, 2023, 549
  • [30] Predicting the immune microenvironment and prognosis with a anoikis-related signature in breast cancer
    Lu, Xiuqing
    Yuan, Qi
    Zhang, Chao
    Wang, Sifen
    Wei, Weidong
    FRONTIERS IN ONCOLOGY, 2023, 13